Chronic GVHD

Ten years after chronic graft-versus-host disease begins, non-relapse mortality reaches 31%, and 62% where the lungs are involved.1

Fewer than half of patients are ever free of systemic immunosuppression.2

31%1
ten-year non-relapse mortality once chronic GVHD begins
62%1
where the lungs are involved
<50%2
of patients are ever free of systemic immunosuppression

Our ambition is a chronic GVHD that resolves, instead of one contained for the rest of a patient's life.

Please note: Halcien Tx operates in a stealth capacity.

We read what comes in and answer where we can. Your details are kept to reply to you and for nothing else. Privacy statement.